Lenire for Tinnitus

What this page helps you decide

What to Expect During the Appointment

1. Step 1

   We take the tinnitus history and measure your hearing.

2. Step 2

   We look for the findings that change the plan: pulsatile tinnitus, one-sided symptoms, sudden change, dizziness.

3. Step 3

   Where there is hearing loss, that is addressed on its own merits before any device pathway is considered.

4. Step 4

   If Lenire is appropriate, we go through what the treatment course involves and what follow-up it needs.

5. Step 5

   You decide with the expectations spelled out, including the possibility that this is not the right tool for your tinnitus.

Related Care

What to expect

What a tinnitus appointment actually involves

1. 1
   We take the history first

   When the sound started, what it sounds like, whether it is in one ear or both, what makes it better or worse, and how much it is affecting sleep, concentration, stress and daily life.

2. 2
   A hearing evaluation, because tinnitus rarely travels alone

   Tinnitus and hearing loss commonly occur together, even in patients who have not noticed any hearing difficulty. Testing may include a hearing evaluation, speech understanding, middle-ear measures and an ear inspection.

3. 3
   Tinnitus pitch or loudness matching, where it helps

   Some patients benefit from matching the frequency and level their tinnitus most closely resembles. It is not a severity score; it is a starting point for counseling and a way to track change.

4. 4
   We go through the findings in clear language

   What we found, what we did not, and which management options actually apply to you: education, sound strategies, hearing aids, maskers, treating an allergy or earwax that is making it worse, a Lenire candidacy conversation, or a medical referral.

5. 5
   A plan matched to your results and symptoms

   Recommendations are personalized rather than generic, and nobody here will promise you a cure. What the first visit does is establish whether hearing loss, earwax, noise exposure or a medication is part of the picture, and what can be done about the part that is treatable.

Tinnitus care at the Harrison office runs alongside NYHD | TinnitusCare, who have been seeing patients there since February 2024 and whose options include Lenire, a bimodal neuromodulation device holding FDA De Novo authorization for the treatment of tinnitus. De Novo is a marketing authorization for a device type the FDA had not classified before — it is not a finding that the device will work for you, and candidacy is decided after an evaluation. Several of our audiologists are Certificate Holders of Tinnitus Management (CH-TM), recognized by the American Board of Audiology.